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ABSTRACT
Purpose To evaluate outcomes of photorefractive
keratectomy up to −10.00 D of myopia and −4.50 of
astigmatism and to develop a predictive model for the
refractive changes in the long term.
Setting Vissum Corporation and Miguel Hernandez
University (Alicante, Spain).
Design Retrospective-prospective observational series of
cases.
Methods This study included 33 eyes of 33 patients
aged 46.79±7.04 years (range 40–57) operated with
the VISX 20/20 excimer laser with optical zones of
6 mm. No mitomycin C was used in any of these cases.
The minimum follow-up was 15 years. The main
outcome measures were: uncorrected and corrected
distance visual acuity, manifest refraction and corneal
topography. Linear regression models were developed
from the observed refractive changes over time.
Results Safety and efficacy indexes at 15 years were
1.18 and 0.83, respectively. No statistically significant
differences were detected for any keratometric variable
during the follow-up (p≥0.103). 15 years after the
surgery 54.55% of the eyes were within ±1.00 D of
spherical equivalent and 84.85% within ±2.00 D. The
uncorrected distance visual acuity at 15 years was 20/25
or better in 60.6% of the eyes and 20/40 or better in
72.73% of the eyes. The correlation between the
attempted and the achieved refractions was r=0.948
(p<0.001) at 1 year, and r=0.821 (p<0.001) at
15 years. No corneal ectasia was detected in any case
during the follow-up.
Conclusions Photorefractive keratectomy is a safe
refractive procedure in the long term within the range of
myopia currently considered suitable for its use, although
its efficacy decreases with time, especially, in high myopia.
The model developed predicts a myopic regression of 2.00
D at 15 years for an ablation depth of 130 mm.
INTRODUCTION
It is over 25 years since the first photorefractive
keratectomy (PRK) procedure was performed in
1987 by Dr Theo Seiler in Berlin.1 In October
1995, PRK became the first Food and Drug
Administration approved laser treatment for the
correction of myopia and myopic astigmatism.2–4
In the year 1990, the first laser in situ keratomi-
leusis (LASIK) procedure was performed and this
technique started to gain popularity, based princi-
pally on the rapid and painless visual rehabilitation
of the patients.5 Also, corneal haze is less promin-
ent after LASIK than after PRK.6–11 These factors
made LASIK the first option for surgeons to correct
ametropia for a long period of time.
However, it has been shown that both techni-
ques, LASIK and PRK, are safe, efficient and pre-
dictable in correcting myopia.12 Moreover, despite
the previously mentioned disadvantages of PRK
compared with LASIK, PRK has its advantages such
as lower risk of corneal ectasia after surgery,
steeper learning curve and lower financial cost.
These reasons have led surgeons to reconsider the
use of this refractive technique in recent years.
Although there are some long-term reports about
PRK,12–14 there are very few studies evaluating the
outcomes of PRK with follow-up longer than or
equal to 15 years.15 16
The main purpose of the present study is to
analyse the topographical and refractive stability of
myopic eyes within the range of ametropia
accepted as suitable for this surgery, 15 years post-
operatively. In addition, based on the observed out-
comes, a model to predict the refractive status in
the long term is developed.
PATIENTS AND METHODS
Study design
Retrospective-prospective observational series of
cases.
Patients
Thirty-three eyes of 33 patients (13 male and 20
female) aged 46.79±7.04 years (range 40–57) with
myopia up to −10.00 D and astigmatism up to
−4.50 D were evaluated 15 years after PRK. Data
of up to 10 years follow-up were obtained from
our databases, while most of the data at 15 years
had to be obtained by contacting the patients by
phone. At 15 years, there was an important number
of dropouts compared with the sample analysed in
previous studies with follow-up of 10 years,13 14
because some of the patients could not be con-
tacted because of changes in address or phone
number, because some patients were living abroad
or because they declined to participate in the study.
The mean value of the spherical refractive error
was −3.92±2.52 (−10.00 to 0.00). The mean
value of the cylinder was −1.12±0.87 (−4.50 to
0.00), and the mean spherical equivalent (SE) was
−4.16±0.57 (−1.25 to −10.75). The distribution
of the refractive error was as follows: 12 eyes
(36.36%) had SE less than or equal to −3.00 D, 11
(33.33%) between −3.00 and −6.00 D and 10
(30.30%) higher than −6.00, up to −10.75 D. The
mean preoperative pachymetry was 543.68±46.87
(475 to 647) and the ablation depth was 63.99
±31.37 (13.53 to 135). All the optical zones
ablated were 6 mm.
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Preoperative and postoperative examinations
A complete ophthalmological examination was performed pre-
operatively and postoperatively, including measurement of mani-
fest refraction, cycloplegic refraction, uncorrected distance
visual acuity (UDVA), corrected distance visual acuity (CDVA),
slit lamp biomicroscopy, dilated funduscopy, applanation tono-
metry and corneal thickness using the DGH-500 pachymeter
(DGH Technology, Exton, Pennsylvania), or Alcon Ocuscan RxP
Ophthalmic Ultrasound System (Alcon Laboratories, Forth
Worth, Texas). Visual acuity was measured using a standard
Snellen acuity chart at 6 m. Corneal topography was evaluated
using EyeSys topographer (EyeSys Corneal Analysis System,
Houston, Texas; preoperative to 5 years of follow-up), Orbscan
I slit-scanner (Bausch & Lomb; only at 5 years or 10 years of
follow-up) and Costruzione Strumenti Oftalmici (CSO) corneal
topography system (CSO, Florence, Italy) at 10 years and
15 years follow-up.
To obtain the preoperative measures, patients stopped using
contact lenses 4 weeks before the surgery. The follow-up con-
sisted of evaluations at 3 months, 1 year, 2 years, 5 years,
10 years and 15 years.
Inclusion and exclusion criteria
Inclusion criteria for surgery were: patients over 25 years old
with stable refraction for at least 6 months before surgery,
normal peripheral retina or treated with photocoagulation when
necessary, no previous ocular surgery, and no corneal diseases,
glaucoma or history of ocular trauma. Exclusion criteria for
surgery were: patients under 25 years old, or keratoconus
suspect, active ocular or systemic disease likely to affect corneal
wound healing, pregnancy and nursing.
Surgical technique
All cases were operated at the same institution (Vissum IOA,
Alicante, Spain). The procedure was carried out using topical
anaesthesia of oxybuprocaine 0.4%. A 193 nm VISX 20/20B
excimer laser, software V.3.2, (VISX, Santa Clara, California,
USA) was used. During surgery, patients fixated on the laser’s
helium-neon fixation light. Optical zones of 6 mm were used.
Astigmatism was corrected by sequential ablation with an area
of 6.0×4.5 mm. Epithelial debridement was performed up to
7–8 mm using manual debridement. Re-treatments were per-
formed by reablating the stromal bed after manual or laser
de-epithelisation. No case of this study received treatment with
mitomycin C for haze prevention.
Statistical analysis
For the statistical treatment of the data, V.17.0 of SPSS for
Windows (SPSS, Chicago, Illinois, USA) was used.
Kolmogorov-Smirnov test was applied for all data samples in
order to check normality. When parametric statistical analysis
was possible, Student’s t test for paired data was applied to
assess the significance of differences between preoperative and
postoperative data, whereas the Wilcoxon rank-sum test was
applied when it was not possible. For the comparison of several
related samples the Friedman test was used. The level of signifi-
cance used was always the same (p<0.05). Bivariate correlations
were evaluated using Pearson’s or Spearman’s correlation coeffi-
cients, depending on whether normality could be assumed
or not.
RESULTS
In table 1 we show the relevant data of the refractive and visual
outcomes observed in this series.
Visual outcomes
UDVA (in decimal scale) changed from 0.20±0.45 (range 0.05–
0.60) to 0.57±0.27 (range 0.20–1.00) 3 months after surgery
(p<0.001, Wilcoxon test). UDVA increased significantly from
3 months to the 2nd year after the operation (p=0.006,
Wilcoxon) and, remained stable during the rest of the follow-up
(p=0.195, Friedman test).
CDVA decreased from 0.83±0.20 (range 0.40–1.20) to 0.78
±0.19 (range 0.50–1.00) 3 months after surgery (p=0.030,
Wilcoxon). During the rest of the follow-up there was a continu-
ous trend towards the improvement of CDVA (p<0.001,
Friedman test). CDVA at 15 years was significantly better than
the preoperative value (p=0.002, Wilcoxon). Figure 1A shows
the change in Snellen lines at 15 years. At 1 year the safety
index was 0.97±0.21 and 69.70% of the eyes gained lines of
vision or remained the same while at 15 years 90.91% of the
eyes gained lines of vision or remained the same. The safety
index at 15 years was 1.18±0.32, significantly higher than the
value achieved at 1 year (p<0.001, Wilcoxon).
The efficacy indexes at 1 year and 15 years were: 0.79±0.32
and 0.83±0.39, respectively. No statistically significant differences
were found between these variables (p=0.360, Student’s t test for
paired samples). As can be seen in figure 1B, 60.6% of the eyes
had UDVA equal to or better than 20/25 15 years after the surgery.
Refractive outcomes
The refractive evolution of the sample is shown in figure 2. The
mean value of the sphere changed from a preoperative value of
−3.92±2.52 D (range 0 to −10.00) to −0.51±1.04 D (range
−3.00 to +2.75) 3 months after the surgery (p<0.001,
Wilcoxon). Refractive cylinder changed from −1.12±0.87 D
(range −4.50 to 0.00) to −0.31±0.42 D (range −2.00 to 0.00)
and the SE from −4.16±3.96 (range −10.75 to −1.25) to
−0.57±0.95 (range −3.50 to 2.38) 3 months after surgery
(p<0.001, Wilcoxon).
The attempted versus achieved SE refraction is present in
figure 3A, B. The predictability at 1 year was r2=0.948
(p<0.001), and r2=0.821 (p<0.001) at 15 years.
After the surgery, no statistically significant differences were
detected in the sphere or the SE during the whole follow-up
(p>0.251, Friedman test). However, a statistically significant
increase in the refractive cylinder was found (p<0.001, Friedman
test). The comparisons between 3 months and 15 years or 1 year
and 15 years showed no statistically significant differences for the
sphere or the SE except for the cylinder (see table 1).
The total myopic increase in the sphere during the follow-up
was −0.10±0.60 D and −0.61±0.60 in the cylinder. This repre-
sents a mean myopic increase of −0.028 D in the SE per year.
Fifteen years after the surgery 54.55% of the eyes were
within ±1.00 D and 84.85% within ±2.00 D.
Keratometric changes
The mean keratometry changed from a preoperative value of
44.05±1.34 D (range 41.38–43.68) to 40.90±2.15 D (36.63–
44.13) 3 months after the surgery. No significant differences
were detected in any keratometric variable during the complete
period of the follow-up (p≥0.103, Friedman test) and the com-
parisons between 3 months and 15 years or 1 year and 15 years
did not show any statistical differences either.
Re-treatments
A total of 13 eyes were re-treated (39.39%): during the 1st post-
operative year 11 eyes (33.33%) were re-treated; considering
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Table 1 Keratometric refractive and visual evolution and comparisons at different moments of the follow-up
Variable 3 months 1 year 2 years 5 years 10 years 15 years
Global comparison
(Friedman test.
p Value)
3 months–15 years
comparison (Wilcoxon
test. p Value)
1 year–15 years
comparison (Wilcoxon
test. p Value)
UDVA
Mean±SD 0.57±0.27 0.65±0.26 0.73±0.26 0.67±0.27 0.69±0.28 0.70±0.28 0.111 0.090 0.690
95% CI (0.46 to 0.66) (0.54 to 0.75) (0.62 to 0.83) (0.58 to 0.78) (0.56 to 0.77) (0.55 to 0.77)
CDVA
Mean±SD 0.78±0.19 0.81±0.18 0.84±0.17 0.84±0.16 0.88±0.17 0.95±0.15 <0.001 <0.001 <0.001
95% CI (0.68 to 0.84) (0.71 to 0.87) (0.75 to 0.90) (0.78 to 0.90) (0.81 to 0.95) (0.90 to 1.00)
Sphere (D)
Mean±SD −0.51±1.04 −0.18±0.60 −0.19±0.66 −0.35±0.70 −0.29±0.81 −0.63±1.17 0.277 0.867 0.283
95% CI (−0.77 to 0.01) (−0.32 to 0.20) (−0.37 to 0.22) (−0.56 to 0.10) (−0.53 to 0.15) (−1.07 to 0.15)
Cyl (D)
Mean±SD −0.31±0.42 −0.21±0.31 −0.27±0.41 −0.55±0.76 −0.57±0.49 −0.80±0.38 <0.001 <0.001 <0.001
95% CI (−0.58 to −0.18) (−0.65 to −0.09) (−0.55 to −0.11) (−0.80 to −0.25) (−0.92 to −0.43) (−1.14 to −0.73)
Sph Eq (D)
Mean±SD −0.57±0.95 −0.32±0.61 −0.38±0.66 −0.49±0.70 −0.46±0.69 −0.93±1.15 0.251 0.213 0.056
95% CI (−0.96 to −0.19) (−0.46 to −0.03) (−0.49 to 0.01) (−0.79 to −0.20) (−0.82 to −0.18) (−1.47 to −0.52)
K1 (D)
Mean±SD 40.29±2.21 39.99±2.22 40.20±2.11 40.16±1.93 40.20±1.83 40.12±2.11 0.779 0.172
95% CI (39.77 to 41.28) (39.28 to 40.93) (39.43 to 40.98) (39.53 to 40.94) (39.63 to 40.97) (39.37 to 40.87) 0.103
K2 (D)
Mean±SD 41.51±2.17 41.27±2.24 41.50±1.95 41.46±1.77 41.38±1.71 41.26±2.00 0.740 0.556 0.336
95% CI (40.97 to 42.48) (40.54 to 42.20) (40.78 to 42.22) (40.85 to 42.15) (40.77 to 42.07) (40.55 to 41.97)
KM (D)
Mean±SD 40.90±2.15 40.63±2.19 40.85±1.99 40.81±1.79 40.79±1.70 40.69±2.02 0.172 0.640 0.140
95% CI (40.39 to 41.86) (39.92 to 41.55) (40.12 to 41.58) (40.21 to 41.52) (40.22 to 41.50) (39.98 to 41.41)
CDVA, corrected distance visual acuity; KM, mean curvature power; UDVA, uncorrected distance visual acuity.
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5 years after the surgery, 13 eyes (39.39%) had undergone
re-treatment. Out of these 13 eyes, 6 had only one re-treatment,
6 two re-treatments and 1 three re-treatments. After this period
of time none of the eyes was re-treated.
Complications related to the surgery
The most frequent complication after PRK was haze. Haze was
barely perceptible or traces in all patients except in one case in
which it was mild to moderate and persisted 2 years after the
surgery. Few other complications were found. One patient
developed endothelial pigment dispersion without affecting
visual acuity. One patient developed sterile peripheral stromal
infiltrates but they resolved spontaneously. No corneal ectasia
was detected during the follow-up.
Correlation analysis
The preoperative sphere was significantly correlated with the
myopic regression in the SE (r=0.586, p=0.002, Spearman). The
ablation depth was correlated in a similar manner with the refract-
ive regression (r=−0.603, p=0.001, Spearman). This is because
the preoperative sphere and the ablation depth are also strongly
correlated to each other (r=−0.977, p<0.001, Spearman).
Two linear regression models were developed. The first one
for the relation between the preoperative sphere and the cylin-
der and the ablation depth:
Ablation depth ¼ 6:929 12:072 Preop Sphere ðDÞ
 2:952 PreopCylinder ðDÞ ð1ÞFigure 1 (A) Change in Snellen lines 15 years after photorefractivekeratectomy. (B) Cumulative Snellen visual acuity (20/_) at 15 years.
Figure 2 Refractive evolution during
the follow-up.
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Predictability was R2=0.969, p<0.001. No influential points or
outliers were detected: Mean Cook distance=0.077±0.031.
The unstandardised residuals were normally distributed
(p=0.200) confirming homoscedasticity of the model. The
value of the Durbin-Watson test was 1.993 showing the inde-
pendence of the residuals. Multicollinearity tests were also
examined, providing VIFS (variance inflation factors) equal to
1.187. Low values for the condition indexes were confirmed
with a maximum value of 4.332.
This regression model showed an ablation depth of about
12.1 μ for each dioptre of myopia and nearly 3 μ per dioptre of
astigmatism for the VISX 20/20 excimer laser for a 6 mm
optical ablation zone. This represents around 13.6 μ per diop-
tres of the SE.
The second linear regression model correlates the regression
in myopic regression at 15 years after the surgery and the abla-
tion depth:
Sphere regression at 15 years ¼ 1:781 0:029
 AblationDepth ðmÞ ð2Þ
Predictability was r2=0.317, p=0.003.
From equation (1), for a preoperative sphere of −10 D and
−5.00 D of astigmatism an ablation depth of 142.41 μ is
predicted. If we use this value in equation (2) a regression of –
2.35 D is predicted 15 years after the surgery (see table 2).
DISCUSSION
In the present study we confirmed that PRK is a safe technique
in the long term for as far as 15 years. This confirms previous
studies also with a long follow-up albeit shorter than in our
study.12–14 17–21
The CDVA increased significantly after the third postoperative
month because of the decrease in the corneal haze. The UDVA
increased significantly from the 3 month to the 2nd year after
the operation (p=0.006, Wilcoxon). Afterwards, there was a
slight decrease in UDVA, possibly because of regression and/or
increase in lenticular sclerosis.
Regarding predictability of the refraction, the results vary
among different studies. This is due, in our opinion, to differ-
ences of the populations under study. The preoperative refract-
ive error, age of the patients, optical zone used and duration of
the follow-up have an important impact in the postoperative
refractive error. In the present study we found that 54.5% of
eyes were within ±1.00 D and 84.85% within ±2.00 D,
15 years after PRK.
In a previous study of our investigational group, focused on
eyes with myopia higher than 6 D,14 we found that 58% of eyes
Figure 3 (A) Attempted versus
achieved spherical equivalent refraction
(D) 1 year after photorefractive
keratectomy (PRK). (B) Attempted
versus achieved spherical equivalent
refraction (D) 15 years after PRK.
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were within ±1.00 D and 78% were within ±2.00 D 10 years
after PRK.
In 2012, Guerin et al15 published the results of 39 eyes with
myopia up to −7.00 D and astigmatism up to −1.50 D, 16 years
after surgery. They reported that 79.5% of the eyes were within
±1.00 D and 94.9% between ±2.00 D. So, the residual spher-
ical error was lower in that study. However, the preoperative
refractive error of the patients was lower (in the present study
up to −10.00 D of myopia and −4.50 D of astigmatism).
Moreover, the optical zone in the study by Guerin et al was
5 mm, less than in our study (6 mm). These differences result in
a higher mean ablation depth in our group of patients (strongly
correlated with the myopic regression). This may explain the
differences obtained in the residual refractive error.
Another recent study was developed by Vestergaard et al,16
with high and low myopic eyes and a follow-up of between 13
years and 19 years. They showed that in the low myopia group
72% of eyes were within the range ±1.00 D of spherical error
at the end of the follow-up and 47% of the eyes in the high
myopia group were within ±1.00 D. Therefore, the average per-
centage of eyes in this range is not very different from the per-
centage found in the current investigation (also with eyes with
low and high myopia).
Other studies of PRK for moderate myopia with a follow-up
of 2 years or less, found that between 40.5% and 90% of eyes
were within ±1.00 D after surgery, confirming the variability in
the results mentioned.4 7 22 23
Long-term studies of myopic regression after PRK for low to
moderate myopia reported that the refraction stabilises between
3 months and 6 months, but the time for stabilisation is longer
for the higher corrections.17–19 In our group of patients, the SE
was stable between 2 years and 10 years after the surgery. After
this time we observed a slight but continuous increase in the
refractive error. This refractive change may be associated with
keratometric regression and lenticular sclerosis.
We found that the preoperative sphere and the ablation depth
were significantly correlated with the refractive regression. The
predictive model developed revealed a myopic regression of
−0.029 D at 15 years/μ of cornea ablated.
As can be seen in table 2, the refractive regression depends on
the sphere and the cylinder. The combination of both para-
meters must be taken into account to predict the changes in the
refraction. Moreover, the quantity of the astigmatism could be a
notable limitation for this surgery because a combination of a
high sphere with a high cylinder would lead to extreme flatten-
ing of one of the meridians.
It should be mentioned that the ablation depth is also related
to the size of the optical zone. The larger the optical zone, the
greater the ablation depth. The ablation of large optical zones is
desirable to diminish effects such as halos and glare as much as
possible, but the side effect is an increase in the ablation depth.
However, the new generation excimer lasers, based on multiple
ablation zones, allow correction of each dioptre of the SE with
an ablation of around 15 mm for a standard myopic ablation
zone of 6.7 mm. This quantity is greater than that found for the
Visx 20/20 (13.6 μ/D of the SE for an optical zone of 6.0 mm)
but the difference is not great and leads us to think that the
long-term result of PRK with the new generation lasers will not
differ greatly from the results of the current study.
Regarding re-treatments, previous studies with a shorter
follow-up found a re-treatment rate ranging between 23% and 50%
after PRK for moderate myopia.7 22 24 We found a rate of 33.3% in
the 1st year after the surgery and 39.9% 5 years after PRK.
The most common complication after surgery was haze.
However, no patients had haze after 15 years and only one
showed mild haze after 2 years. In addition, we found a higher
incidence of haze in eyes with high myopia. This coincides with
the findings of O’Connor et al. They reported that most of the
eyes with haze were myopic by over −5.00 D.19 In our study a
total of 12 eyes had myopia higher than −5.00 D. Seven of
these eyes (58.33%) had haze at some time during the
follow-up, while 9 of 21 eyes (42.86%) with myopia lower than
5.00 D had haze at some time. Another study25 also showed
that the risk of haze is greater when the ablation is greater than
80 mm. This is also consistent with the study of O’Connor and
the current study.
In conclusion, PRK has been seen in this study to be a safe
procedure for the correction of myopia in the long term up to
15 years when performed within the limits of today’s standards
for the indication of excimer laser myopia surgery. However the
efficacy is lower and the rate of complications higher if the abla-
tion depth increases. In mean terms, after 15 years, corneal ker-
atometry was relatively stable and corneal haze was transient
and continued to fade over time. Finally, based on the outcomes
observed in this investigation, we have developed a predictive
model, which may help refractive surgeons to predict the out-
comes of PRK for periods of over 5 years.
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